Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by PBaelishhon May 26, 2023 2:38pm
103 Views
Post# 35466209

RE:"...assess different market capitalization initiatives..."

RE:"...assess different market capitalization initiatives..."Proph I do not understand your purpose on this forum; 99% of your posts are parroting, not analysis.  I find the fact that you have cited market cap in your post to be rather hilarious!  Just like Gagnon citing the TSX 50 recognition in the annual report.

So...

Gilles (or Proph) - as you read these posts - please explain how it makes sense that Ceapro made it onto the TSX Venture 50 based on their criteria.
"The 2023 TSX Venture 50 winners were selected based on year-over-year performance across three equally-weighted criteria: growth in market capitalization, share price appreciation and value traded for the year ended December 31, 2022."

Alternatively Sir, please explain how Ceapro's market cap was $4,738,811 as at December 31, 2021.

I have will now pose the same questions to the TMX.
<< Previous
Bullboard Posts
Next >>